| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/28/2004 | CN1471391A Composition and method for treatment of hypertriglyceridemia |
| 01/28/2004 | CN1470258A Chinese medicine for treating chest paralysis |
| 01/28/2004 | CN1470248A Oral liquor for preventing and treating presbyopia and its preparation method |
| 01/28/2004 | CN1470247A Bone repairing material |
| 01/28/2004 | CN1470246A Liquid antiacid composition |
| 01/28/2004 | CN1136154C Active oxygen eliminating agent concentrated liquid and its producing process and active oxygen eliminating agent powder |
| 01/28/2004 | CN1136000C Medicine for treating scleroderma and its preparing process |
| 01/28/2004 | CN1135999C Medicine for treating chicken disease of respiratory tract |
| 01/28/2004 | CN1135998C Medicine for curing chicken trachitis |
| 01/28/2004 | CN1135994C Exterior-applied chinese medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| 01/27/2004 | US6683059 Constructs for suppression of oncogenic transformation, tumorigenesis and metastasis |
| 01/27/2004 | US6682762 Poultry and livestock feed additive |
| 01/27/2004 | CA2179682C Pharmaceutical, orally applicable composition |
| 01/27/2004 | CA2109150C Heat sealable shrink laminate |
| 01/22/2004 | WO2004006945A1 Tablet composition containing chinese orthodox medicine extract and process for producing the same |
| 01/22/2004 | WO2004006899A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 01/22/2004 | WO2004006833A2 Bowel cleansing composition |
| 01/22/2004 | WO2004006801A2 Treatment for dry eye syndrome |
| 01/22/2004 | WO2003090778A3 Dna vaccine combined with an inducer of tumor cell apoptosis |
| 01/22/2004 | WO2003066022A3 Stable pharmaceutical composition useful for treating gastrointestinal disorders |
| 01/22/2004 | WO2003051979A3 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 01/22/2004 | WO2003026570A3 Reduced toxicity cisplatin formulations and methods for using the same |
| 01/22/2004 | US20040014782 Combination therapy for the treatment of diseases involving inflammatory components |
| 01/22/2004 | US20040014729 Bone disorders; anticancer agents |
| 01/22/2004 | US20040014700 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents |
| 01/22/2004 | US20040014692 Controlling concentration of cholesterol, leptin and serotonin in blood; dietetics |
| 01/22/2004 | US20040014601 Adjust concentration of plant protein using peracetic acid, salicylic acid; gene encoding transcription factor |
| 01/22/2004 | US20040014188 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| 01/22/2004 | US20040013746 Antidepressants for treating manic disorders, psychosis, comprising ethyl cellulose, talc, polyvinylpyrrolidone |
| 01/22/2004 | US20040013745 Process of making a supplement for digestive ailment |
| 01/22/2004 | US20040013744 Antibiotic ointment for treating skin rash; simple and inexpensive |
| 01/22/2004 | US20040013743 A daily vitamins, also comprising a low dose phytoestrogen, for perimenopausal and menopausal women; nutraceuticals |
| 01/22/2004 | US20040013730 Insertion into vagina; prevention, therapy for infections |
| 01/22/2004 | US20040013660 Synergistic mixtures |
| 01/22/2004 | DE10327874A1 Injektionsanästesiemittel in Kombination mit Xenon Injektionsanästesiemittel in combination with xenon |
| 01/22/2004 | DE10319837A1 Verwendung von Edelgasen, insbesondere Argon oder Xenon, zur Prophylaxe oder Therapie von Innenohrerkrankungen Use of noble gases, in particular argon or xenon, for the prophylaxis or treatment of inner ear disorders |
| 01/22/2004 | DE10231104A1 Verwendung von mikronisiertem Calciumsulfat-Dihydrat zur Verringerung des Auftretens von Hypocalcaemien bei Milchkühen Use of micronized calcium sulfate dihydrate for reducing the occurrence of Hypocalcaemien in dairy cows |
| 01/22/2004 | DE10230752A1 Neue Arzneimittelkompositionen auf der Basis von Magnesiumsalzen und Fibrinolytika New pharmaceutical compositions based on magnesium salts and fibrinolytics |
| 01/22/2004 | DE10230027A1 Neue Arzneimittelkombinationen auf der Basis von Natriumkanalblockern und Magnesiumsalzen New drug combinations on the basis of sodium channel blockers and magnesium salts |
| 01/22/2004 | CA2782498A1 Tablet composition containing kampo medicinal extract and its manufacturing process |
| 01/22/2004 | CA2492374A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 01/21/2004 | EP1382338A1 Controlled release tablet comprising tilidine and a photoprotectant |
| 01/21/2004 | EP1382263A2 Use of calcium in acidic oral compositions for the reduction of tooth erosion caused by acid |
| 01/21/2004 | EP1381571A2 Antioxidants in clusters of structured water |
| 01/21/2004 | EP1381455A1 Stable aqueous colloidal dispersion, method for preparing same |
| 01/21/2004 | EP1229802A4 Food product and process for manufacturing same |
| 01/21/2004 | CN1469736A Use of a porous carrier |
| 01/21/2004 | CN1468603A Prepn of potassium magnesium aspartate for injection |
| 01/21/2004 | CN1468599A Prepn for local treatment of tumor and chemotherapy of lymph and its prepn process |
| 01/21/2004 | CN1135110C Oil preparation for treating burn and scald |
| 01/20/2004 | US6680305 Physiologically acceptable aqueous solutions and methods for their use |
| 01/20/2004 | US6680135 Substrate with a photocatalytic coating |
| 01/20/2004 | US6680073 Aqueous composition containing salicylic acid, copper salt and complex, peroxide and polyhydroxyaromatic |
| 01/20/2004 | CA2052532C Hardening agent for affected tissues of the digestive system |
| 01/15/2004 | WO2004004786A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 01/15/2004 | WO2004004782A1 Adjuvant containing xenon |
| 01/15/2004 | WO2004004754A1 Novel medicament combinations based on magnesium salts and fibrinolytics |
| 01/15/2004 | WO2004004745A1 Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 01/15/2004 | WO2004004723A1 Novel medicament combinations based on sodium channel blockers and magnesium salts |
| 01/15/2004 | WO2004004686A2 Cartilage enhancing food supplements and methods of preparing the same |
| 01/15/2004 | WO2004004638A2 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 01/15/2004 | WO2004004631A2 Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body |
| 01/15/2004 | WO2004004483A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/15/2004 | WO2004004464A1 Novel rho inhibitors |
| 01/15/2004 | WO2003089434A3 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF |
| 01/15/2004 | WO2002072010A3 Taxane prodrugs |
| 01/15/2004 | US20040010215 Silver-containing compositions, devices and methods for making |
| 01/15/2004 | US20040010002 Also identifying agents that are useful for alleviating and inhibiting lymphoproliferative disorders or inhibiting metastasis of lymphatic tumors |
| 01/15/2004 | US20040009964 Compositions and methods for the treatment of matrix metalloproteinase-related diseases |
| 01/15/2004 | US20040009955 Combating metastatic bone cancer with a polyphosphonate and a soluble radium-223 or - 224 salt or complex. |
| 01/15/2004 | US20040009895 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 01/15/2004 | US20040009248 Method for improving the cell protection |
| 01/15/2004 | US20040009246 Preparation for regulating lower bowel function |
| 01/15/2004 | US20040009238 Exogenenous nitric oxide gas (gNO) therapy in wound healing |
| 01/15/2004 | US20040009237 Copper lowering treatment of inflammatory and fibrotic diseases |
| 01/15/2004 | US20040009236 Bowel cleansing composition |
| 01/15/2004 | US20040009235 Hydroxyapatite with specified particle size and a pharmaceutical carrier; osteoporosis; calcium deficiency |
| 01/15/2004 | US20040009207 Dissolved oxygen is >/= 75 mg/l water; prophylaxis and treatment of conditions connected with an unsatisfactory oxygen supply of the inner organs |
| 01/15/2004 | US20040009172 Biweekly subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha in combination with another drug which is useful for treating the disorder |
| 01/15/2004 | US20040007093 Vaporizing with electric target within vacuum, operating spinner that provides ultrasonic vibration, cooling and reducing adhesive force, then collecting powders with static-electronic collector; for resisting tumors/immunology |
| 01/15/2004 | DE10328272A1 Medikament mit Xenon und NO Medicine with xenon and NO |
| 01/15/2004 | DE10328271A1 Medikament mit Xenon und einer NO-Quelle Medicine with xenon and an NO source |
| 01/15/2004 | DE10227756A1 Biologisches Mittel zur Bekämpfung von Durchfallerkrankungen bei Tieren Biological agents for controlling diarrheal diseases in animals |
| 01/15/2004 | CA2491712A1 New drug combinations based on magnesium salts and fibrinolytics |
| 01/15/2004 | CA2491484A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 01/15/2004 | CA2491445A1 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 01/15/2004 | CA2491217A1 New drug combinations based on sodium channel blockers and magnesium salts |
| 01/15/2004 | CA2490952A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/15/2004 | CA2488384A1 Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body |
| 01/14/2004 | EP1379276A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 01/14/2004 | EP1379261A2 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
| 01/14/2004 | EP1379260A2 Methods for treating the inflammatory component of a brain disorder |
| 01/14/2004 | EP1379231A2 Pharmacologically active strong acid solutions |
| 01/14/2004 | EP1379207A1 Composition for freshening nostrils and sinus cavities |
| 01/14/2004 | EP1328156A4 Composition for generating chlorine dioxide |
| 01/14/2004 | EP0870435B1 Mineral composition |
| 01/14/2004 | CN1468259A Immunotherapy for chronic myelocytic leukemia |
| 01/14/2004 | CN1468102A Modified prodrug forms of ap/amp |
| 01/14/2004 | CN1467050A Method for making gold particle and application thereof |